Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
京東健康
06618
5
百度集團-SW
09888
| (Q1)2025/06/30 | (FY)2025/03/31 | (Q1)2024/06/30 | (FY)2024/03/31 | (Q4)2024/03/31 | (Q3)2023/12/31 | (Q2)2023/09/30 | (Q1)2023/06/30 | (FY)2023/03/31 | (Q4)2023/03/31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 營業總收入 | 4.04%79.63億 | 11.48%333.41億 | 1.94%76.54億 | -4.73%299.08億 | -12.23%61.58億 | -7.60%78.05億 | -6.71%84.37億 | 9.06%75.08億 | 35.01%313.92億 | -0.20%70.16億 |
| 主營業務成本 | 1.85%49.26億 | 8.26%223.57億 | 3.48%48.37億 | -13.54%206.51億 | -9.77%45.28億 | -10.50%53.01億 | -18.11%61.48億 | -14.00%46.74億 | 39.38%238.83億 | -18.04%50.18億 |
| 毛利 | 7.80%30.37億 | 18.65%109.84億 | -0.61%28.17億 | 23.29%92.58億 | -18.40%16.3億 | -0.80%25.04億 | 48.93%22.89億 | 95.56%28.34億 | 22.75%75.09億 | 120.28%19.98億 |
| 營業費用 | 8.73%12.55億 | 10.98%44.84億 | 18.85%11.54億 | 3.38%40.4億 | -6.94%11.38億 | 8.64%9.77億 | 7.99%9.55億 | 7.61%9.71億 | 6.60%39.08億 | 33.95%12.23億 |
| 營業利潤 | 7.15%17.82億 | 24.58%65億 | -10.75%16.63億 | 44.90%52.18億 | -36.48%4.93億 | -6.02%15.27億 | 104.37%13.34億 | 240.61%18.63億 | 46.91%36.01億 | 13,802.79%7.75億 |
| 營業外利息收入與支出淨額 | -34.43%-547.4萬 | 43.54%-731.1萬 | -32.29%-407.2萬 | -223.43%-1,294.9萬 | -123.52%-372.8萬 | -17.12%-330.4萬 | -97.15%-283.9萬 | -180.33%-307.8萬 | 401.38%1,049.1萬 | 2,077.20%1,585萬 |
| 營業外利息收入 | ---- | 10,612.35%867.7萬 | ---- | -99.57%8.1萬 | -99.77%4.4萬 | --0 | ---- | ---- | 860.35%1,901.5萬 | 877.06%1,899.4萬 |
| 營業外利息支出 | 34.43%547.4萬 | 22.70%1,598.8萬 | 32.29%407.2萬 | 52.86%1,303萬 | 19.97%377.2萬 | 17.12%330.4萬 | 96.85%287.6萬 | 180.33%307.8萬 | 56.09%852.4萬 | 158.55%314.4萬 |
| 投資淨收益 | -72.74%899.1萬 | 107.39%1.21億 | 159.24%3,298.6萬 | 72.39%5,820.3萬 | 468.80%2,244.5萬 | -31.69%1,498.7萬 | 252.78%804.7萬 | 127.34%1,272.4萬 | 167.68%3,376.3萬 | -61.70%394.6萬 |
| 被指定為現金流套期的金融工具損益 | ||||||||||
| 終止確認可供出售金融資產損益 | ||||||||||
| 聯營企業及其他參股權益產生的收益 | ||||||||||
| 特殊收入(費用) | 130.67%137.2萬 | 110.05%540.4萬 | -196.48%-447.4萬 | -1,890.89%-5,375.4萬 | -283.54%-1,157.9萬 | -3,863.72%-4,938萬 | 1,542.70%256.8萬 | 668.96%463.7萬 | -100.80%-270萬 | -100.88%-301.9萬 |
| 減:資本性資產減值 | ---- | -79.94%307.5萬 | --307.5萬 | --1,533.2萬 | --615.1萬 | --918.1萬 | ---- | ---- | --0 | --0 |
| 減:其他特殊費用 | -198.07%-137.2萬 | -122.07%-847.9萬 | 130.17%139.9萬 | 1,323.04%3,842.2萬 | 79.79%542.8萬 | 3,163.95%4,019.9萬 | -1,542.70%-256.8萬 | -668.96%-463.7萬 | 100.80%270萬 | 100.88%301.9萬 |
| 其他營業外收入(費用) | -95.81%87.9萬 | 146.61%2,276萬 | 187.21%2,098.1萬 | -76.47%922.9萬 | -146.13%-314.6萬 | -88.52%252.4萬 | -62.75%254.6萬 | 104.34%730.5萬 | -28.31%3,921.8萬 | 72.01%682萬 |
| 稅前利潤 | 4.64%17.88億 | 27.28%66.42億 | -9.36%17.08億 | 41.74%52.18億 | -37.86%4.97億 | -10.52%14.92億 | 103.62%13.45億 | 240.04%18.85億 | 14.39%36.82億 | 127.14%7.99億 |
| 所得稅 | 5.51%5.83億 | 24.19%20.84億 | -9.00%5.53億 | 37.94%16.78億 | -42.42%1.37億 | -10.09%4.89億 | 89.00%4.45億 | 204.87%6.07億 | 14.81%12.16億 | 92.32%2.38億 |
| 除稅後利潤 | 4.23%12.05億 | 28.74%45.58億 | -9.53%11.56億 | 43.62%35.41億 | -35.92%3.59億 | -10.73%10.04億 | 111.71%9億 | 259.76%12.78億 | 14.19%24.65億 | 146.09%5.61億 |
| 持續經營利潤 | 4.23%12.05億 | 28.74%45.58億 | -9.53%11.56億 | 43.62%35.41億 | -35.92%3.59億 | -10.73%10.04億 | 111.71%9億 | 259.76%12.78億 | 14.19%24.65億 | 146.09%5.61億 |
| 歸屬于少數股東的淨利潤 | ||||||||||
| 歸屬於母公司的淨利潤 | 4.23%12.05億 | 28.74%45.58億 | -9.53%11.56億 | 43.62%35.41億 | -35.92%3.59億 | -10.73%10.04億 | 111.71%9億 | 259.76%12.78億 | 14.19%24.65億 | 146.09%5.61億 |
| 優先股派息 | ||||||||||
| 其他優先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 歸屬于普通股股東的淨利潤 | 4.23%12.05億 | 28.74%45.58億 | -9.53%11.56億 | 43.62%35.41億 | -35.92%3.59億 | -10.73%10.04億 | 111.71%9億 | 259.76%12.78億 | 14.19%24.65億 | 146.09%5.61億 |
| 總派息金額 | ||||||||||
| 基本每股收益 | 4.22%52.15 | 28.26%197.3 | -10.24%50.04 | 42.19%153.83 | -37.16%15.44 | -12.05%43.42 | 110.18%39.22 | 257.60%55.75 | 14.11%108.19 | 145.45%24.57 |
| 稀釋每股收益 | 4.20%52.13 | 28.62%197.2 | -9.60%50.03 | 43.24%153.32 | -36.49%15.44 | -11.10%43.42 | 111.05%38.96 | 258.65%55.34 | 14.29%107.04 | 145.56%24.31 |
| 每股派息 | 0 | 68.09%79 | 0 | 113.64%47 | 88.24%32 | 0 | 200.00%15 | 0 | 15.79%22 | 21.43%17 |
| 貨幣單位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
| 會計準則 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |